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ABSTRACT
A novel approach to DNA probe hybridization and
heteroduplex analysis, termed directed heteroduplex
analysis (DHDA) is presented here to illustrate its utility
in simplification of human lymphocyte antigen (HLA)-
typing. By strategic labeling of single-stranded probe
sequences, DHDA allows the identification of specific
heteroduplex structures that contribute to the
differentiation of DQAI and DQB1 alleles. Because of
the high degree of polymorphism among major
histocompatibility complex class 11 second exon
sequences, this analysis of 50 different heteroduplex
molecules provides evidence of the importance of
unpaired bases and mismatched base pairs and their
effect on heteroduplex electrophoretic-mobility
differences. This strategy is further used to genotype
accurately a family for DQAI which was previously
analyzed by sequence specific oligonucleotide (SSO)
probe hybridization. To differentiate by SSO-typing
among the DQA1 and DQB1 alleles analyzed in this
study requires the use of 23 different probes.
Equivalent results are obtained by DHDA using only
three probes. Therefore, this study suggests that
accurate HLA-typing can be simplified by DHDA.
Additionally, DHDA may be useful for differentiation of
DNA sequence polymorphisms in other genetic
systems.
INTRODUCTION
The cell surface glycoproteins encoded by the major
histocompatibility complex class II (MHC class II) genes are
responsible for activating CD4+ lymphocytes through antigen
presentation (1, 2) and play important roles in transplantation
immunology (3-5), in determining the nature of clinical
manifestations in response to infectious agents (6-9), and in
autoimmunity (10). The polymerase chain reaction (PCR) (11)
facilitates rapid identification of the DNA sequence
polymorphisms within the second exons of MHC class II genes.
These genes encode the portion of mature MHC II proteins
responsible for antigen presentation to T-cell receptors during
initiation of an immune response. Identifying this molecular
diversity within MHC class II molecules has been motivated in
large part by the clinical significance of matching donor and host
in solid organ (i.e. kidney, heart, lung, liver) and bone marrow
transplants. Advantages of PCR based human lymphocyte antigen
(HLA)-typing over serological or mixed lymphocyte reaction
assays include increased specificity and sensitivity in detecting
most allelic polymorphisms based upon DNA sequence
differences. PCR based haplotyping has also been successfully
applied to a wide variety of human populations because DNA
sequence polymorphisms fail to occur in the conserved regions
used as PCR primer annealing sites of genomic templates (12).
In contrast, the utility of reagents for immunologically based
HLA-typing are compromised by unidentified polymorphisms
seen in non-European populations (13).
Detection of differences among PCR amplified MHC II alleles
has employed the differential hybridization of sequence-specific
oligonucleotide (SSO) probes to PCR products amplified by locus-
specific primers (14). Because SSO detection involves the use
of well over 100 probes (DRB1 = 66; DQA1 = 10; DQB1 =
13; DPA1 = 4; DPB1 = 26) (15), complete MHC class II
haplotyping becomes complicated not only by the numbers of
reagents required, but also because of the different hybridization
and washing conditions required for probe specificity. These
factors have influenced the development of alternative methods
for allelic differentiation based upon amplified fragment length
polymorphism (AFLP) analysis (16), single stranded
conformational polymorphism (SSCP) (17), heteroduplex analysis
(18-21), or denaturing gradient gel electrophoresis (22). Each
of these alternative approaches reveals polymorphic differences
among alleles following gel electrophoresis; the banding patterns,
however, are frequently very complex even in homozygotes.
This study presents a novel PCR-based approach termed
directed heteroduplex analysis (DHDA) employing the strategic
PCR-based labeling of three DNA probes to achieve accurate
and simple genotyping of all DQA1 and DQB1 alleles.
Heteroduplex molecules (HDs), formed between a labeled allelic
probe sequence and unlabeled allelic PCR products from
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individual human samples, can be visualized by autoradiography
because the resulting HD pattern is comprised of a single product
in homozygous individuals or two products in heterozygous
individuals. To verify the sensitivity and specificity of this new
approach, we used DHDA to genotype a previously characterized
three generation family at DQA1. Analysis of the relative gel-
mobility differences between individual HDs suggests that the
number, spacing and chemistry of unpaired or non-standard
Watson-Crick base pairs influence the stability of HDs.
Therefore, this study also suggests that strategic positioning of
mutations may lead to new approaches for detecting DNA
sequence polymorphisms through DNA probe hybridization.
MATERIALS AND METHODS
DNA samples
Human genomic DNA was prepared from Epstein -Barr virus-
transformed B lymphoblastoid cell lines (BLCL) following
proteinase K (100 ,Lg/ml); sodium lauryl sulfate (SDS) (0.1 %)
lysis and phenol chloroform extraction (23). BLCL, homozygous
for DQAl and DQBl were obtained from the 10th International
Histocompatibility Workshop (24). Additional BLCL representing
members of Family 104 were obtained from the CEPH (Centre
pour l'Etude du Polymorphisme Humain) repository.
PCR amplification
PCR amplification of DQA1 and DQB 1 second exon fragments
was directed by previously defined primers that anneal to highly
conserved regions overlapping the 5' and 3' intron-exon borders.
These include: the DQA1 specific primers (GH26 [+ strand]
5'-CCCAAGCTTGTGCTGCAGGTGTAAACTTGTACCAG-3'
and GH27 6 [- strand] 5'-CCCAAGCTTCACGGATCCGGT-
AGCAGCGGTAGAGTTG-3'); and DQB1 specific primers
(DQB1 A [+ strand] 5'-CCCAAGCTTCATGTGCTACTTC-
ACCAACGG-3' and DQB1 B [- strand] 5'-CCCAAGCTT-
CTGGTAGTTGTGTCTGCACAC-3'). All primers were
modified by the addition of a synthetic 5' HindI site. PCR
amplifications were carried out in a solution (100 ,ud) containing
10 pmoles of the appropriate + strand and - strand primers, 10
mM Tris-HCl, 1.5 mM MgCl2, 0.01% gelatin, 100 AM
dATP, dGTP, dCTP, TTP, 2.5 units of Taq DNA polymerase
(Perkin Elmer Cetus, Norwalk, CT), and 100 ng of purified
human genomic DNA or 2 /tl of an M13 phage stock (1 x 1010
plaque-forming units/ml) containing a single DQA1 or DQB1
functional or pseudogene allele (probe template). The
temperature-cycling conditions for DQA1 amplification was 94°C
for 30 seconds (denaturation), 50°C for 30 seconds (annealing)
and 72°C for 30 seconds (extension) for 40 cycles. For DQB1
the same conditions were used except that the annealing
temperature was changed to 58°C. All amplification reactions
were performed in the Perkin-Elmer 9600 Turbo PCR machine
(Cetus, Emeryville, CA). Unlabeled PCR products from
individual human samples were concentrated 4-fold by ethanol
precipitation and resuspension in 25 Al of TE pH 7.6.
Radioactive PCR amplification
Two different strategies were utilized for the incorporation of
radioactive nucleotides into PCR products derived from probe
templates. Double-stranded labeling of the PCR products was
performed by reducing the dATP concentration to 50 zM and
adding 10 ACi of [ct-32P]dATP (3000 Ci/mMole) as modifica-
tions to the reaction conditions (see above). Single-stranded
labeling of the PCR products was achieved by utilizing + or -
strand primers (10 pmoles) that had been labeled with 70 4Ci
['y-32P]ATP (3000 Ci/mMole)(Amersham Co., Arlington Hts.,
IL) and treated with T4 polynucleotide kinase using conditions
recommended by the manufacturer (U.S. Biochemicals,
Cleveland, OH). Double-strand and single-strand labeled PCR
products were diluted by the addition of 200 t,d of TE pH 7.6
prior to DHDA.
Cloning of PCR products
Following amplification from human genomic DNA templates,
non-radioactive PCR products were concentrated by ethanol
precipitation and subjected to HindIl digestion in 20 A1 following
the suppliers' recommended protocol (Boehringer-Mannheim,
Indianapolis, IN). As the HindHi recognition site is not found
within known MHC class II second exons, this treatment modifies
only the PCR products at the synthetic HindIII sites introduced
at the 5' end of each primer sequence. HindIll digested MHC
class II PCR products were separated from the primers and small
HindIll digestion products by electrophoresis on a 2% agarose
gel. The DQA 1 and DQB 1 PCR products were further purified
from excised agarose and cloned into Ml3mpl9 RF, that had
been previously treated with HindIII and calf intestinal alkaline
phosphatase (Boehringer-Mannheim, Indianapolis, Indiana). The
DNA sequence of individually cloned MHC class II second exons
was detennined by standard dideoxy-nucleotide chain termination
sequencing (25).
DHDA
Five j.d of the unlabeled PCR products (derived from individual
human genomic DNA templates concentrated 4-fold following
ethanol precipitation) were mixed with 5 /d of the labeled PCR
products (derived from specific DQA1 or DQB1 M13 phage
stocks). One drop of mineral oil was added to overlay the
mixture. Following a two minute incubation at 97°C to denature
the double-stranded PCR products, HD formation was promoted
by slowly cooling the reactions to room temperature (ramp time
from 97°C to room temperature was 45 minutes). HD solutions
(7 Al) were mixed with sample dye buffer (0.25 % bromophenol
blue; 0.25% xylene cyanol FF; 30% glycerol) (3 tdl) and samples
of 3.5 Al were loaded onto a 5 % polyacrylamide
(l9:1(acrylamide:bis acrylamide)), 2.7 M urea gel (21), unless
noted otherwise. Electrophoresis was performed on 50 cm
sequencing gels at 35 mAmps for 5 hours in 1 x TBE. The
temperature of the gel was maintained between 40 and 45'C.
Gels were dried in vacuo prior to autoradiography.
RESULTS
DNA probe development applied to directed heteroduplex
analysis (DHDA)
In contrast to previous studies (18-21) in which heteroduplex
formation has been applied to HLA analysis, this study has
employed strategic labeling of single stranded probe sequences
to simplify the HD banding patterns and facilitate HLA-typing,
referred to as directed heteroduplex analysis (DHDA). Functional
DQA1 alleles, 0102 and 0501, and the pseudogene, DQB2,
second exon fragments were cloned individually into M13mpl9
and sequenced to verify identity with previously analyzed alleles
(26) before serving as probe templates for DHDA HLA-typing.
The DNA sequence of the probe M13-DQA1*0501 was
compared to major functional DQA1 alleles to identify the
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Figue 1. DNA sequences for the DQA1I alleles (excluding DQA1*0501) are compared to the DHDA probe sequence M13-DQA1*O5O1. Sequences and the numerical
codon coordinates were obtained from the latest compilation of MHC II alleles (26). (A) The + strand of the probe (underlined) is analyzed for complementary
base pairing to the- strand of the DQA1I alleles. (B) The - strand of the probe (underlined) is analyzed for complementary base pairing to the + strand of the
DQA1I alleles. A (-) signifies that the allelic nucleotide is complementary to that which is present at the same position in the probe. Mismatches are indicated by
the presence of the appropriate residue (A, G, C or T) for a each allele. Base pair mismatches are read top strand to bottom strand as they are oriented in the figure.
Mismatches which have been shown to be least stable as non-standard Watson-Crick base pairs (27) are placed on a black background. The deletion in the probe
sequence at nucleotides 133-135 is represented by *. Unpaired bases of the HD molecule are on a gray background.
number, positions and nucleotides involved in base pair
mismatching in resulting HD molecules formed between each
functional allele and both the + and the - strands of the probe
(Fig. lA and iB). The number of pairwise differences between
DQAI alleles and M13-DQAI *0501 ranges from 8-29
(3.5-12.9%) over a total length of 225 nucleotides. Base pair
mismatches have been subclassified by thermodynamic stability
as determined by Aboul-ela et al. (27), as 'stable' (black
letters/white background) or relatively 'unstable' mismatches
(white letters/black background). Total numbers of base palr
mismatches, and stable versus unstable mismatches, for each
allelic HD product are provided in Fig. 2 below panels B and
C. Additionally, a three base pair deletion (*)occurs in
DQAI*0201, 0401, 0501 and 0601.
Correlating predicted DQA1 allelic HD polymorphisms with
electrophoretic-mobility differences
As segments of single-stranded DNA within HDs causes gel
retardation (during electrophoresis), relative to completely double-
stranded DNA, and because the predicted DQA1 HDs (Fig. lA
and iB) exhibit numerous differences in the positions of unpaired
and mismatched base pairs, it was hypothesized that each HD
would vary in the organization of its double and single stranded
segments. If so, these unique DQAI HD electrophoretic
mobilities would permit genotypic analysis of this individual
genetic locus (Fig. 2). As seen in the HD banding patterns for
homozygous typing cell lines (HTCLs; representing the most
frequently observed DQAI alleles) when probed with
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Figure 2. Directed heteroduplex analysis of DQA1 alleles from homozygous typing
cell lines utilizing M13-DQA1*0501 as the probe template. Allelic HD molecules
are identified below each lane. Panel A. M13-DQA1*0501 labeled in both +
and - strands detects 2 heteroduplex bands per allele. Panel B. M13-DQA1*0501
labeled in the + strand through incorporation of end labeled GH26 detects 1
heteroduplex band per allele (A - :P+). Panel C. M13-DQA1*0501 labeled in
the - strand through incorporation of end labeled GH27 detects 1 heteroduplex
band per allele (A+ :P-). The band detected in lanes labeled 0501 identifies the
position of the homoduplex product. Note that the positions of the heteroduplex
bands detected by the double stranded probe (A) correspond directly to the band
positions detected by each of the single stranded probes (B and C). The data below
panels B and C summarize the numbers of mismatches which are most likely
to form unstable and stable base pairs (27). A identifies the allelic HDs affected
by the unpaired bases at nucleotide coordinates 133-135. The 3 base pair insert
is not added into the mismatch totals. The band(s) appearing in all lanes in the
upper part of each panel is felt to be the result of HD formation with the
simultaneously amplified DQA2 pseudogene.
M13-DQA1*0501, every DQA1 allele, with the exception of
DQA1 *0601, can be distinguished by the unique mobility of one
or both of its HD bands. In Fig. 2A, HDs are detected following
double-strand probe labeling. The resulting pattern for each allele
includes two HD bands (A+:P- and A-:P+; A = HTCL
allelic strand and P = probe strand). When the P+ strand
(Fig. 2B) or the P- strand (Fig. 2C) are labeled independently
the detected DQA1 HD polymorphism for each allele includes
only one of the HD bands. Thus, it becomes possible to correlate
the significance of unpaired and mismatched nucleotides in each
allelic HD (identified in Fig. IA and iB) with relative mobility
differences of the two products detected for each allele (intra-
allelic HDs) and among products for other alleles (inter-allelic
Figure 3. DQAI genotyping of Family 104 utilizing labeled + strand PCR
products amplified from the template M13-DQA1*0102. The DQA1 genotypes
of the HTCLs are shown below the 8 lanes in the left side of the panel.
Relationships within Family 104 are shown above the 14 lanes in the right side
of the panel. Genotypes of family 104 members as determined by SSO detection
(28) are as follows: 10413 = 0401 orO601/0401 orO601; 10414 = 0101/0201;
10401 = 0201/0401 orO601; 10402 = 0301/0501; 10403 = 0201/0501; 10404
= 0501/0401 or 0601; 10405 = 0201/0501; 10406 = 0201/0501; 10407 =
0501/0401 or 0601; 10408 = 0301/0401 or 0601; 10409 = 0501/0401 or 0601;
10410 = 0301/0401 or 0601; 10411 = 0501/0401 or 0601; 10412 = 0201/0501.
DQA1 genotyping based upon these same samples was also 100% consistent with
SSO-typing when M13-DQA1*0501 was used as the DHDA probe (data not
shown). Note that DQA1*0101 and DQA1*0102 are differentiated using the +
strand labeled DQA1*0102 as the probe. Also, DQA1*0501 is detected by the
presence of a heteroduplex band in contrast to detection through a homoduplex
band as in Fig. 2. Heteroduplex molecules containing the three base bulge at
nucleotides 133-135 are DQA1*0201, 0401, 0501 and 0601.
HDs). For example, when comparing relative effects of gel
retardation among the intra-allelic HDs, the HD with the highest
ratio of unstable:stable mismatches (Fig. 2, bottom) exhibits the
greatest relative gel retardation (exception is DQA1*0301).
To verify the presence of DQA1*0501 through detection of
an informative HD, samples can be probed with M13-
DQA1*0102 for genotypic analysis, as seen in Fig. 3.
Coincidently, M13-DQA1*0102 also detects a more distinctive
HD polymorphism between DQA1 *0101 and DQA1 *0 102 (see
Fig. 3, Lanes 1 and 2 marked 0101 and 0102, respectively).
DHDA genotying of DQA1 and DQB1
Application ofDHDA to genotyping of a previously characterized
family was used to test the specificity of allelic identification by
comparing HDs between HTCLs and previously SSO-genotyped
Family 104, as detected by M13-DQA1*0102 (Fig. 3). Thus,
grandparental alleles DQAl*0401 or 0601 (FAFA-10413
DQA1*0401 or 0601/0401 or 0601) and DQA1*0201
(MOFA-10414 = DQA1 *0101/0201) were inherited by their
son, FA-10401 (DQA1*0201/0401 or 0601), as expected.
Further, all offspring from FA-10401 and MO-10402
(DQA1*0301/0501) also resulted in predictable combinations of
their parental DQA1 alleles (either DQA1*0201 or 0401 or 0601
and DQA1*0301 or 0501). Therefore, DQA1 genotyping by
DHDA was 100% consistent with the SSO-genotyping results
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Figure 4. Differentiation of DQB1 alleles utilizing labeled + strand (Panel A)
and - strand (Panel B) PCR products amplified from the pseudogene template
M13-DQB2. DQB1 genotypes are shown below each lane. Note that the lane
labeled 0201/0303 contains two HD products, where the electrophoretically more
mobile product is 0201 and the less mobile product is 0303. The direction of
electrophoresis was in the same orientation as the figure. Electrophoresis of HDs
detected by the DQB2+ probe (Panel A) was performed on a 5% polyacrylamide
(37.5: 1(acrylamide:Bis acrylamide)), 2.7 M urea gel.
(28). These results further demonstrate that individual alleles are
detected with comparable sensitivity. Also, among heterozygous
family members, the positions of individual allelic HD products
enables clear identification of all genotypes. Finally, the
electrophoretic-mobilities of each allelic HD product is completely
consistent between homozygous and all heterozygous individuals.
To provide complete haplotypic analysis of the genes encoding
the membrane bound DQ heterodimer, the second exon sequence
of the DQB2 pseudogene (M13-DQB2) was cloned and developed
as a DHDA probe (Fig. 4). HTCLs were used to identify unique
DQB1 HD polymorphisms, with one exception, BLCL
heterozygous for DQB1*0201 and 0303. Fortuitously, these
results show that all functional allele, except DQB1*0402, can
be identified by a unique electrophoretic polymorphism.
Therefore, not only do these results demonstrate the alternative
probe strategy based on the pseudogene sequence, the results also
demonstrate the general applicability of DHDA to genotypic
analysis at a different genetic locus.
DISCUSSION
Strategic differences between DHDA and SSO-based HLA-
typing. This study utilizes a novel strategy for simplifying DQA1
and DQB1 genotyping, termed DHDA. This method provides
significant potential for overall application to HLA-typing. A
comparison of DHDA to SSO-typing identifies numerous
advantages of this strategy. First, complete differentiation of 7
of 8 DQA1 alleles and 12 of 13 DQB1 alleles was accomplished
with 3 probes (DQAl = 2 and DQB1 = 1). For comparable
results at least 23 SSOs are required (DQA1 2 10 and DQB1
> 13) (21). The reduced number of probes needed for DHDA-
typing is based on the fundamental differences in the application
ofDNA probes in DHDA and SSO analyses. SSO-typing relies
on probe hybridization to detect and differentiate alleles. DHDA-
typing relies on probe hybridization to detect alleles, but
differentiation of alleles is based on the polymorphic
electrophoretic mobilities of individual allelic HD molecules.
Because differentiation is not linked to detection, DHDA can be
accomplished using low stringency solution hybridization and
relatively fewer numbers of probes. This feature of DHDA
eliminates control of hybridization and washing conditions
required for SSO probe hybridization specificity and eliminates
the maintenance of the large collection of SSO probes. Allelic
differentiation based on electrophoretic-mobility differences in
DHDA also permits simultaneous positive identification of
multiple alleles following a single probe hybridization in contrast
to the necessity of using a complete SSO probe series, thus
providing a means for more efficient utilization of precious DNA
samples. Additionally, identifying novel alleles is based on
2 0 0 positive detection of HD products with unique electrophoretic-
mobilities.
An advantage of the SSO-typing system is based on non-
radioactive detection. DHDA can be easily converted to non-
radioactive reagents tnrougn strategic use ot biotmylateO primers
and strepavidin-linked enzyme detection systems.
Strategic differences between DHDA and other PCR-based
approaches to HLA-typing
Comparisons to other PCR-based HLA-typing techniques further
illustrate the superiority of DHDA. DHDA does not involve
additional enzymatic modification of locus-specific PCR products
as required for allele-specific identification in AFLP
methodologies. Advantages of DHDA over single-strand
conformational polymorphism (SSCP) and conventional
heteroduplex analysis (HDA) are based upon the complexity of
heterozygous banding patterns. By SSCP unique allelic mobility
differences are less obvious than by DHDA (especially with
respect to DQB1) and therefore allelic differentiation is more
accurate by DHDA.
When compared to HDA, DHDA represents a significantly
improved alternative. First, identifying alleles in homozygous
individuals by HDA is not possible because the only product
formed is a homoduplex. Homoduplex molecules, regardless of
sequence differences, exhibit identical electrophoretic mobilities
when they are the same length. Clearly, DHDA differentiates
homozygous individuals (Figs. 2, 3 and 4). Regarding the
complexity of genotyping heterozygotes, in both DHDA and
HDA, all possible homoduplex and HD molecular combinations
are allowed to form in each individual reaction. The important
difference lies in which HD molecules are detected. In HDA the
difference lies in which HD molecules are detected. In HDA the
detected bands will represent HDs formed between alleles A and
B (A+:B- and A-:B+) in addition to the homoduplex
on techniques that incorporate label into all double-stranded DNA
molecules, the number of different HD banding patterns is equal
to the number of possible heterozygous combinations (28 for
DQA1 and 78 for DQB1). To pursue locus-specific genotyping
of unknown samples would then require a prohibitively large
number of positive allelic controls. In DHDA the detected
products will represent the HDs formed between unlabeled
alleles, A and B, and the labeled probe sequence, P (A+:P-
and B+:P- orA-:P+ and B-:P+). Since all of the detected
products form in reference to the labeled probe sequence, the
number of different HD banding patterns is reduced to the number
of alleles at any given locus (8 for DQA1 and 13 for DQBl).
By using known heterozygous samples or by combining even
larger groups of defined alleles the number of lanes per gel
dedicated to positive controls can be further reduced to the desired
number.
A.
000000000000.
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4546 Nucleic Acids Research, 1993, Vol. 21, No. 19
Advantages of pseudogene-based probes in DHDA
The strategic use of the pseudogene-based probe provides two
further advantages to genotyping individual loci. First each
functional allele is detected as a polymorphic HD product. Thus,
homozygotes will be distinguished from heterozygotes by the
presence of one instead of two HD products in their DHDA
autoradiogram, unless products for two allelic HDs exhibit the
same electrophoretic-mobility. As shown in the differentiation
of DQB1 alleles (Fig. 4), this technical problem may be resolved
by using the opposite strand probe. Second, each of the MHC
class II loci have associated pseudogenes and conserved PCR
primer annealing sites permit amplification of both the functional
and pseudogene alleles. By using the pseudogene as the probe,
unlabeled pseudogene PCR products amplified from individual
human samples will be pulled into the homoduplex band and out
of the heteroduplex field where they may obscure visualizing the
functional allelic HDs.
Molecular analysis of HD structures
Conceptually, gel retardation of HDs (relative to homoduplexes)
is due to regions of the molecule which are single stranded. DNA
sequence comparisons between the probe M13-DQA1*0501 and
the eight functional DQA1 alleles (Fig. IA and LB) suggest that
the structure of these HD molecules is likely to be affected by:
1) deletions; 2) the number of base pair mismatches; 3) the
intervals between mismatches; 4) the A-T versus G-C richness
of the sequence flanking mismatches; and 5) the chemical stability
between mismatched base pairs.
These predictions are supported by the data provided in Figs.
2 and 3. In Fig. 2, all HD molecules formed between the alleles
without the deletion between nucleotides 133- 135 (not deleted
at nucleotides 133-135 = Ai-) (DQA1*0101, 0102, 0103 and
0301) and the probe, M13-DQA1*0501, which is deleted at
nucleotides 133- 135 (A +), are affected by a 3 base bulge and
demonstrate greater gel retardation than HDs formed between
A + alleles (0201, 0401 and 0601). Consistent with this
observation, when the probe is A - (M 13-DQA 1 *0 1 02), all A +
alleles demonstrate greater gel retardation relative to the - alleles
(see Fig. 3). The presence of frameshift mutations, such as this,
have been shown to affect HD structure in various ways (29-31).
Of relevance here, the juxtaposition of deleted and inserted
nucleotides force kinks into the structures of resulting HDs
because of 'bulged-out' (30), unpaired nucleotides. As kinked
molecules do not move through the polyacrylamide matrix as
easily as molecules without kinks, the kinked HD molecules
exhibit relatively greater amounts of gel retardation.
The effect of individual mismatches and combinations of
mismatches contribute to additional structural differences and
promote unique HD mobilities that serve to differentiate
individual alleles further. For example, it is generally observed
that HDs with the greatest number of mismatches show the
greatest gel retardation. Interestingly however, intra-allelic HDs
are affected by the same number of base pair mismatches, yet
some exhibit dramatically different electrophoretic mobilities
(alleles 0101, 0102 and 0103). When compared to the position
of the homoduplex band detected in lanes marked 0501, gel
retardation of the A-:P+ HDs for 0101, 0102 and 0103
(Fig. 2B) is approximately two-fold greater than observed for
the A+:P- HDs (Fig. 2C). Since the primary difference
between intra-allelic HDs is the bases present at unpaired and
mismatched positions, this suggests that the chemical stability
between mismatched base pairs is an important factor in HD
structure. Aboul-ela et al. have measured the thermodynamic
stabilities of all dinucleotide combinations when positioned in the
center of a 9-mer (+ strand sequence dCA3XA3G; - strand
sequence dCT3YT3G; in IM NaCl, pH 7.0) (27). This study
found that mismatches involving G-residues were relatively more
stable than mismatches involving C-residues (stabilities of A-A
and T-T mismatches were comparable to C-T and T-C
mismatches) (27). While the sequences and buffer conditions
involved in DQA1 heteroduplex formation differ, the observations
synthesizing the number, spacing, sequence context and
thermodynamic stabilities of base pair mismatches appear to be
consistent with the hierarchy of base pair stability proposed above.
Therefore it might be predicted that regions of HDs which are
most likely to be single stranded are those which contain the most
destabilizing combination of base pair mismatches.
The data compiled below panels B and C in Fig. 2 suggest
that the majority of the inter-allelic and intra-allelic mobility
differences may be explained by the number of unstable
mismatches relative to stable mismatches; the greater this ratio
the greater the observed gel retardation. Thus, the A-:P+ HDs
exhibit greater gel retardation than the A + :P - HDs for alleles
0101, 0102 and 0103 while the converse is observed for alleles
0201, 0401 and 0601. For alleles 0101, 0102 and 0103 the
A - :P+ HD molecules are affected by more unstable than stable
mismatches (the majority of which [10] are observed within the
37 nucleotides flanking the deleted bases 133- 135; see Fig. lA).
In contrast the corresponding A+ : P- HDs are affected by more
stable than unstable mismatches (Fig. 1B). For alleles 0201, 0401
and 0601 the A+:P- HDs show greater numbers of unstable
mismatches and therefore greater relative gel retardation than their
A-:P+ intra-allelic counterparts.
The DQA 1 *0301 HDs are an exception to these observations.
Here A+:P- is affected by relatively fewer unstable, as
compared to, stable mismatches (unstable = 9; stable = 12) yet
it displays greater gel retardation than A- :P+ (unstable = 12;
stable = 9). To explain this inconsistency we note that the looped
out bases are comprised of 3 purines (AGA) in A+ :P- while
the complementary pyrimidine bases (TCT) are unpaired in
A-:P+ . The relative effects of unpaired purines versus
pyrimidines have recently been used to explain the HD
electrophoretic mobility differences observed in detecting the
cystic fibrosis mutation and other experimentally derived
mutations (29, 30). In these systems unpaired purines always lead
to greater gel retardation than the reciprocal pyrimidine bulges.
Finally, the effects of individual base pair mismatches can be
observed since some alleles differ from each other at only one
or two nucleotide positions. Specifically, alleles DQA1*0101 and
0102 differ by a G to C transversion at nucleotide 67; alleles
DQA 1*0102 and 0103 differ by an A to T transversion at
nucleotide number 41 and by a G to A transition at nucleotide
89; alleles DQA1*0401 and 0601 differ by an A to T transversion
at nucleotide 41. When M13-DQA1*0102 is used as the probe,
0101 is differentiated from 0102 (which is detected only as a
homoduplex) in only the A - :P+ HD (Fig. 3 lanes 1 and 2;
marked 0101 and 0102, respectively). Here the mismatch at
nucleotide 67 is C-C (unstable) in contrast to a G-G (stable) in
the A+:P- HD. The mismatched base pairs between
M 13-DQA1*0501 and DQA1*0102, 0103, 0401 and 0601 will
be treated together. By comparing the mismatches between the
probe (M13-DQA1*0501) and DQA1 *0601 it appears that neither
unstable mismatch A-A (in A-:P+) nor T-T (in A+:P-)
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promotes mobility differences which allow differentiation between
DQA1 *0401 and 0601. This suggests that the same mismatch
between M13-DQA1*0501 and DQA1*0103 will similarly result
in no measurable differences between DQA1*0102 from 0103.
Therefore it is suggested that the A+:P- mobility difference
between the DQA1*0102 and 0103 HDs in Fig. 2B must be due
to the A-C mismatch (unstable) at nucleotide 89. The reciprocal
G-T mismatch (stable) between the probe and 0103 in the
A-:P+ HD does not change the mobility of 0103 relative to
0102 (Fig. 2C). These observations suggest that in the sequence
contexts where they are found the C-C mismatch (nucleotide 67
in DQA1*0101) and the A-C mismatch (nucleotide 89 in
DQA1*0103) result in a single stranded 'bubbles' (30) and
promote HD gel retardation, whereas the G-G mismatch
(nucleotide 67 in DQA1*0101), the A-A and T-T mismatches
(nucleotide 67 in DQA1 *0103 and 0601) and the G-T mismatch
(nucleotide 89 in DQA1*0103) may result in stable non-standard
Watson-Crick base pairs and have no observed effect on HD
mobility.
It appears that this type of analysis of the factors affecting HD
structure may help to direct mutagenesis of specific probe
sequence motifs to further differentiate alleles (DQA1 *0401 and
0601) which differ by only a single nucleotide. Based on the
observations presented in this study if the + strand of the M13
based probe could be changed to a C residue the mismatch for
DQA1*0601 would be A-C while the mismatch for DQA1*0401
would be T-C. Since the A-C mismatch appears to be
characterized by the greatest instability, differentiation between
DQA1*0401 and 0601 might be observed. A further application
of these observations to a larger task is in regard to differentiating
between the highly variable DRB1 and DPB1 alleles. Because
of the large number of alleles observed at these genetic loci it
may be possible to use the existing functional alleles or
pseudogenes as informative probes for successful genotyping
through the DHDA strategies described in this study.
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